title title


title

  title
title title title title title title
 
 
 
 
 
 
 

The Burrill B. Crohn Research Foundation has helped bring two outstanding clinical investigators from France and Portugal to Mount Sinai for a full year of study and research. > Read More

 
 
Immunosuppression in inflammatory bowel disease: how much is too much? Cohen BL, Torres J, Colombel JF. Curr Opin Gastroenterol. 2012 Jul;28(4):341-8.
View article: PMID: 22573191
 
A Survey of Current Practice of Venous Thromboembolism Prophylaxis in Hospitalized Inflammatory Bowel Disease Patients in the United States. Tinsley A, Naymagon S, Trindade AJ, Sachar DB, Sands BE, Ullman TA. J Clin Gastroenterol. 2012 Apr 2.
View article: PMID: 22476043
 

Ulcerative colitis as a progressive disease: The forgotten evidence.Torres J, Billioud V, Sachar DB, Peyrin-Biroulet L, Colombel JF. Inflamm Bowel Dis. 2011 Dec 11.
View article: PMID: 22162423

 
Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Torres J, de Chambrun GP, Itzkowitz S, Sachar DB, Colombel JF .Aliment Pharmacol Ther. 2011 Sep;34(5):497-508.
View article: PMID: 21692821
 
Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Itzkowitz SH, Young E, Dubois D, Harpaz N, Bodian C, Chen A, Sachar DB. Gastroenterology. 1996 Mar; 110(3): 694-704. View article: PMID: 8608878
 
Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis.Itzkowitz SH, Marshall A, Kornbluth A, Harpaz N, McHugh JB, Ahnen D, Sachar DB. Gastroenterology. 1995 Aug; 109(2): 490-7.
View article: PMID: 7615198
 
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S.
Gastroenterology. 2003 Nov; 125(5) :1311-9
View article: PMID: 14598247
 
Recurrence patterns after first resection for stricturing or penetrating Crohn's disease. Sachar DB, Lemmer E, Ibrahim C, Edden Y, Ullman T, Ciardulo J, Roth E, Greenstein AJ, Bauer JJ. Inflamm Bowel Dis. 2009 Jul; 15(7): 1071-5.
View article: PMID: 19229992
 
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A. Clin Gastroenterol Hepatol. 2008 Oct; 6(10): 1112-6.
View article: PMID: 18928936
 
Pouch-ouch. Maser EA, Present DH. Curr Opin Gastroenterol. 2008 Jan; 24(1): 70-4. Review.
View article: PMID: 18043236
 
Colorectal carcinoma in indeterminate colitis. Branco BC, Harpaz N, Sachar DB, Greenstein AJ, Tabrizian P, Bauer JJ, Greenstein AJ. Inflamm Bowel Dis. 2009 Jul;15(7):1076-81.
View article: PMID: 19177428
 
Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Perl DP, Fogarty U, Harpaz N, Sachar DB. Inflamm Bowel Dis. 2004 Nov;10(6):881-3. Review. No abstract available.
View article: PMID: 15626906
 
Is Perianal Crohn's Disease Associated with Intestinal Fistulization? Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J, for the Task Force on Clinical Phenotyping of the IOIBD. The American Journal of Gastroenterology (2005) 100, 1547–1549.
View article:
PMID: 15984979
 
Torres J, de Chambrun GP, Itzkowitz S, Sachar DB, Colombel J-F. Colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Therap 2011, in press.
View article: PMID: 21692821
 
 
 
   
   
   
   

         
  Copyright © 2014 The Burrill B. Crohn Research Foundation, Inc   Home | Privacy Policy | Terms and Conditions | Site Map | Contact Us  
         
  The views expressed and content presented are those of the Foundation and do not necessarily reflect those of Mount Sinai.